Healthcare | May 07, 2026
Free HLA typing for children with thalassaemia launched in India
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies
This is an exciting and meaningful milestone for GRIN Therapeutics
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
The agreement could rise to $900 million if key commercial milestones are met
Hyderabad based 400-bed facility brings AI-driven care, advanced imaging, and integrated clinical systems under one roof
Ajax's lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with first proof-of-concept clinical data to be presented later in 2026
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
Subscribe To Our Newsletter & Stay Updated
